IM Cannabis Corp. Files April 2024 6-K Report
Ticker: IMCC · Form: 6-K · Filed: Apr 4, 2024 · CIK: 1792030
| Field | Detail |
|---|---|
| Company | Im Cannabis CORP. (IMCC) |
| Form Type | 6-K |
| Filed Date | Apr 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, foreign-issuer, reporting
TL;DR
IM Cannabis Corp. filed its April 6-K, standard foreign issuer update.
AI Summary
IM Cannabis Corp. filed a Form 6-K on April 4, 2024, to report information for the month of April 2024. The company is incorporated in Israel and its principal executive offices are located at Kibbutz Glil Yam, Central District, Israel. IM Cannabis Corp. is required to file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates and disclosures for IM Cannabis Corp. as a foreign private issuer, informing investors about the company's ongoing reporting obligations.
Risk Assessment
Risk Level: low — This filing is a routine disclosure for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- IM Cannabis Corp. (company) — Registrant
- April 4, 2024 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Requirement
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information for the month of April 2024 as required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 for foreign private issuers.
Where are IM Cannabis Corp.'s principal executive offices located?
IM Cannabis Corp.'s principal executive offices are located at Kibbutz Glil Yam, Central District, Israel, 4690500.
What is the Commission File Number for IM Cannabis Corp.?
The Commission File Number for IM Cannabis Corp. is 001-40065.
Does IM Cannabis Corp. file annual reports under Form 20-F or Form 40-F?
IM Cannabis Corp. files annual reports under Form 20-F.
What is the SIC code for IM Cannabis Corp.?
The Standard Industrial Classification (SIC) code for IM Cannabis Corp. is 2833, which corresponds to MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.
Filing Stats: 346 words · 1 min read · ~1 pages · Grade level 16.1 · Accepted 2024-04-04 07:11:59
Filing Documents
- zk2431239.htm (6-K) — 10KB
- exhibit_99-1.htm (EX-99.1) — 45KB
- 0001178913-24-001214.txt ( ) — 55KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 . Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____ Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders. Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____ Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IM CANNABIS CORP. (Registrant) Date: April 4, 2024 By: /s/ Oren Shuster Name: Oren Shuster Title: Chief Executive Officer and Director EXHIBIT INDEX 99.1 Form 7 - Monthly Progress Report dated April 4, 2024